Select Page

For more than 20 years, the Clinique médicale l’Actuel, under the direction of Dr. Réjean Thomas, has been bringing together healthcare professionals, with a focus in virology, to learn from guest experts and discuss the most relevant clinical practice challenges facing them today.

ARV therapy: From Our Roots Comes Our Growth

with Dr. Calvin Cohen and Dr. Réjean Thomas



  • Antiretroviral combined treatments
  • Impact of co-formulations on patient adherence
  • The best treatment for each patient
  • Life expectancy of HIV patients
  • Long-term effects of HIV medications on patients’ lives

This activity is supported by
an educational grant from:




During this presentation, Dr. Calvin Cohen tackles the subject of co-formulations and their impact on patient adherence to treatment.

He further discusses the factors to consider when choosing the best treatment for an individual patient and addresses the topic of the long-term effects that these treatments have on the life expectancy of patients.

Réjean Thomas, MD, DHC

Réjean Thomas, MD, DHC


CEO | Founder
Clinique médicale l’Actuel:
Centre of Excellence HIV – STI – Hepatitis
Affiliated with the Centre hospitalier de l’Université de Montréal (CHUM)
Québec, Canada

Calvin Cohen, MD, MSc

Calvin Cohen, MD, MSc


Research Director
CRI New England
Harvard Vanguard Medical Associates
Harvard Medical School
Boston, USA



Only Logged in users can see the full program

ViroChannel has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Réjean Thomas, MD has a financial interest/relationship or affiliation in the form of:
Advisory: AbbVie, Bristol-Myers Squibb Janssen, Gilead, Merck, ViiV Healthcare.

Calvin Cohen, MD, MSc has a financial interest/relationship or affiliation in the form of:
Advisory: Bristol-Myers Squibb, Janssen, Merck, ViiV Healthcare
Consultant: AbbVie
Industry funded research investigator and advisory: Gilead

Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses. No responsibility is taken for errors or omissions. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.